COMSOL NEWS 9 T o deal with multiple drug modalities, functions, and stages of commercialization, the diverse modeling and simulation tools in the biopharmaceutical industry need to provide considerable breadth with suf cient depth. Amgen, a leading multinational biopharmaceutical company, uses multiphysics simulation as a tool in their arsenal at any point in their drug production processes to ensure drug ef cacy and safety. Their various products have treated serious illnesses in millions of people around the world. But behind every product is a plethora of processes, and Amgen employs a diverse portfolio of process models to enhance their work ow. In an industry where process modeling is more prevalent than product modeling, a portfolio such as this is k

Join for free to read